Genentech Patient Foundation
- Assets
- $337.6m
- Revenue
- $3.7b
- Investments
- $0.0
- Employees
- 0
- Location
- South San Francisco, CA
- Founding
- 08/2003
- Data as of
- 12/2023
- EIN
- 46-0500266
Organization Overview
Genentech Patient Foundation is located in South San Francisco, CA. The organization was established in 2003. According to its NTEE Classification (P60) the organization is classified as: Emergency Assistance, under the broad grouping of Human Services and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Genentech Patient Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Genentech Patient Foundation generated $3.7b in total revenue. This organization has experienced exceptional growth, as over the past 6 years, it has increased revenue by an average of 12.7% each year . All expenses for the organization totaled $3.7b during the year ending 12/2023. While expenses have increased by 13.2% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2023
Describe the Organization's Program Activity:
Part 3 - Line 4a
DISTRIBUTION OF PHARMACEUTICAL PRODUCTS TO ELIGIBLE UNINSURED OR UNDERINSURED PATIENTS IN THE UNITED STATES. DURING 2023, THE GENENTECH PATIENT FOUNDATION PROVIDED
$3.7 BILLION WORTH OF PRESCRIPTION DRUGS TO PATIENTS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $3,658,063,399 |
| Interest on Savings | $0 |
| Dividends & Interest | $0 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $0 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $3,658,063,399 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $0 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $61,461,653 |
| Total operating and administrative expenses | $61,461,653 |
| Contributions, gifts, grants paid | $3,634,462,791 |
| Total expenses and disbursements | $3,695,924,444 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $0 |
| Net Accounts receivable | $8,089,366 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $329,500,584 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $337,589,950 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $106,782,806 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $106,782,806 |